{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:22:06Z","timestamp":1787764926188,"version":"build-2784847793"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context:<\/jats:title>\n                    <jats:p>Interleukin-6 (IL-6) is a pleiotropic cytokine that has an important function in the regulation of immunity, inflammation, hematopoiesis, and cancer biosynthesis. Liver cirrhosis is an advanced stage of liver fibrosis, and inflammatory cytokines play a key role in the activation of numerous cells involved in the pathogenesis of fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The aims of this study were to assess serum IL-6 levels in patients with liver cirrhosis, and to study the correlation of IL-6 levels with the disease severity and mortality at 1 month in these patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>This prospective observational study was conducted in the Medicine department of a tertiary care teaching hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>The study was conducted on 50 patients with liver cirrhosis aged 20\u201360 years. Serum IL-6 levels were measured by the chemiluminescence method in all the patients at the time of presentation. The relationships between IL-6 levels and the disease severity, in terms of Child-Turcotte-Pugh (CTP) score and class, and between IL-6 levels and mortality at 1 month, were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>\n                      The continuous variables were expressed as mean and standard deviation, whereas the categorical variables were summarized as frequencies and percentages (%). Non-normally distributed variables were expressed as the median and interquartile range (IQR). The Mann\u2013Whitney\n                      <jats:italic toggle=\"yes\">U<\/jats:italic>\n                      -test was employed for the comparison of two continuous variables and the Kruskal\u2013Wallis test was employed for comparing 3 or more continuous variables. Spearman\u2019s correlation coefficient (\u03c1) was employed to check the correlation between two continuous variables. Logistic regression analysis was used to identify independent predictors of disease outcome.\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05 was considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Most patients were males (82%), and the maximum number of patients were in the age groups of 35\u201344 (32%) and 45\u201354 years (34%). Most of them had decompensated cirrhosis (CTP class B: 42% and CTP class C: 40%). On follow-up, 84% of patients were alive at 1 month, whereas 16% expired. Mean IL-6 levels of the study population were 38.39 \u00b1 39.36 pg\/mL. IL-6 levels showed a positive correlation with grade of ascites (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001), grade of encephalopathy (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001), CTP class (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001), CTP score (\u03c1 = 0.863), international normalized ratio (\u03c1 = 0.356), serum bilirubin (\u03c1 = 0.432), and a negative correlation with serum albumin (\u03c1 = \u22120.344). IL-6 levels were significantly higher in patients who expired in comparison to those who were alive at 1 month (mean: 109.87 \u00b1 45.57 pg\/mL, median [IQR]: 120.13 [73.87\u2013145.60] pg\/mL vs. 24.77 \u00b1 17.60 pg\/mL, 22.55 [11.87\u201335.50] pg\/mL,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001). IL-6 was found to be a significant predictor of disease outcome (odds ratio = 1.084, 95% confidence interval = 0.99\u20131.19).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>IL-6 levels were found to be significantly associated with the severity of liver cirrhosis. It also correlated with the disease outcome; higher levels were found in patients who expired during the follow-up period. Thus, IL-6 may be a reliable and independent predictor of disease severity and outcome in patients with liver cirrhosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aam.aam_271_24","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T05:00:08Z","timestamp":1744088408000},"page":"876-883","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of Interleukin-6 Levels in Patients with Liver Cirrhosis and its Correlation with Disease Severity and Mortality"],"prefix":"10.4103","volume":"24","author":[{"given":"Chavi","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Medicine, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit Pal Singh","family":"Chawla","sequence":"additional","affiliation":[{"name":"Department of Medicine, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarabjot","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Medicine, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Department of Medicine, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Aryan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagarneel","family":"Chaudhuri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"R1-20251015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0016-5085(63)80130-4","article-title":"Capillarization of hepatic sinusoids in man","volume":"44","author":"Schaffner","year":"1963","journal-title":"Gastroenterology"},{"key":"R2-20251015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"R3-20251015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol"},{"key":"R4-20251015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0888-7543(88)90003-1","article-title":"Regional localization of the interferon-beta 2\/B-cell stimulatory factor 2\/hepatocyte stimulating factor gene to human chromosome 7p15-p21","volume":"2","author":"Ferguson-Smith","year":"1988","journal-title":"Genomics"},{"issue":"Suppl 2","key":"R5-20251015","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.2337\/diabetes.54.suppl_2.S114","article-title":"Interleukin-6 and diabetes: The good, the bad, or the indifferent?","volume":"54","author":"Kristiansen","year":"2005","journal-title":"Diabetes"},{"key":"R6-20251015","first-page":"291","article-title":"The role of interleukin-6 in development and progression of atherosclerosis","volume":"22","author":"Dubi\u0144ski","year":"2007","journal-title":"Pol Merkur Lekarski"},{"key":"R7-20251015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.bor.0000218949.19860.d1","article-title":"Interleukin-6 in rheumatoid arthritis","volume":"18","author":"Nishimoto","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"R8-20251015","doi-asserted-by":"crossref","first-page":"e1093722","DOI":"10.1080\/2162402X.2015.1093722","article-title":"Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis","volume":"5","author":"Lippitz","year":"2016","journal-title":"Oncoimmunology"},{"key":"R9-20251015","first-page":"943","article-title":"The relation between pathogenesis of liver cirrhosis, hepatic encephalopathy and serum cytokine levels: What is the role of tumor necrosis factor ?","volume":"58","author":"Goral","year":"2011","journal-title":"Hepatogastroenterology"},{"key":"R10-20251015","first-page":"47","article-title":"The role of interleukin-6 and nitric oxide in pathogenesis of portal hypertension and decompensation of liver cirrhosis","volume":"90","author":"Mirodzhov","year":"2012","journal-title":"Klin Med (Mosk)"},{"key":"R11-20251015","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e31815e7f58","article-title":"IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy","volume":"43","author":"Montoliu","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"R12-20251015","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the study of liver diseases and the European Association for the study of the liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"R13-20251015","first-page":"16","article-title":"Study of alcoholic liver cirrhosis in hospital based patients, Bijapur, Northern Karnataka, India","volume":"7","author":"Patil","year":"2015","journal-title":"Int J Curr Med Appl Sci"},{"key":"R14-20251015","first-page":"592","article-title":"Trends in alcohol-related morbidity and mortality","volume":"103","author":"Williams","year":"1988","journal-title":"Public Health Rep"},{"key":"R15-20251015","doi-asserted-by":"crossref","first-page":"B81","DOI":"10.1093\/gerona\/56.2.B81","article-title":"Interleukin-6 production does not increase with age","volume":"56","author":"Beharka","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R16-20251015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11357-009-9092-5","article-title":"Interleukin-6 plasma level increases with age in an Italian elderly population (\u201cThe Treviso Longeva\u201d-Trelong-study) with a sex-specific contribution of rs1800795 polymorphism","volume":"31","author":"Albani","year":"2009","journal-title":"Age (Dordr)"},{"key":"R17-20251015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.18388\/abp.2011_2286","article-title":"Advanced oxidation protein products and inflammatory markers in liver cirrhosis: A comparison between alcohol-related and HCV-related cirrhosis","volume":"58","author":"Zuwa\u0142a-Jagie\u0142\u0142o","year":"2011","journal-title":"Acta Biochim Pol"},{"key":"R18-20251015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43066-023-00268-6","article-title":"Validity of serum resistin level and IL-6 as prognostic biomarkers of decompensated liver cirrhosis in chronic hepatitis C virus patients","volume":"13","author":"El-Shayeb","year":"2023","journal-title":"Egypt Liver J"},{"key":"R19-20251015","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.dld.2012.07.002","article-title":"Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy","volume":"44","author":"Jain","year":"2012","journal-title":"Dig Liver Dis"},{"key":"R20-20251015","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.1872-034X.2012.01047.x","article-title":"Relationship between IL-6 and ammonia in patients with minimal hepatic encephalopathy due to liver cirrhosis: IL-6 and ammonia in MHE","volume":"42","author":"Luo","year":"2012","journal-title":"Hepatol Res"},{"key":"R21-20251015","first-page":"532615","article-title":"Proinflammatory cytokines (IL-1?, IL-6) and hepatocyte growth factor in patients with alcoholic liver cirrhosis","author":"Prystupa","year":"2015","journal-title":"Gastroenterol Res Pract 2015"},{"key":"R22-20251015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13550-021-00791-w","article-title":"Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization","volume":"11","author":"\u00d6cal","year":"2021","journal-title":"EJNMMI Res"},{"key":"R23-20251015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ckj\/sfv137","article-title":"Pro-inflammatory cytokines: A possible relationship with dialytic adequacy and serum albumin in peritoneal dialysis patients","volume":"9","author":"Milan","year":"2016","journal-title":"Clin Kidney J"},{"key":"R24-20251015","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.cgh.2017.09.017","article-title":"Increased level of interleukin 6 associates with increased 90-day and 1-year mortality in patients with end-stage liver disease","volume":"16","author":"Remmler","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R25-20251015","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1111\/j.1530-0277.2000.tb00012.x","article-title":"Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: Relation to severity of liver disturbance","volume":"24","author":"Fujimoto","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"R26-20251015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","article-title":"Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality","volume":"74","author":"Costa","year":"2021","journal-title":"J Hepatol"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_271_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:51:25Z","timestamp":1787763085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_271_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_271_24","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"2024-12-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}